Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Summary of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):

	March 31, 2021		December 31, 2020
Cash and cash equivalents	$	102,903	$	114,229
Restricted cash		—		388
Total cash, cash equivalent and restricted cash	$	102,903	$	114,617

Schedule of Revenue for Products as Percentage of Total Revenue

Revenue for ClotTriever and FlowTriever products as a percentage of total revenue was derived as follow:

	Three Months Ended March 31,
	2021			2020
ClotTriever		35	%		37	%
FlowTriever		65	%		63	%